Login to your account

Username *
Password *
Remember Me
M-A | Endothelin receptor antagonists do not improve outcomes in idiopathic pulmonary fibrosis.

M-A | Endothelin receptor antagonists do not improve outcomes in idiopathic pulmonary fibrosis.

The potential benefit of endothelin receptor antagonists’ therapy in idiopathic pulmonary fibrosis: A meta-analysis of results from randomized controlled trials – Medicine  

The post M-A | Endothelin receptor antagonists do not improve outcomes in idiopathic pulmonary fibrosis. appeared first on Links Medicus.

Lu 501 fois
Évaluer cet élément
(0 Votes)

About Author

Laissez un commentaire

Assurez-vous d'entrer toutes les informations requises, indiquées par un astérisque (*). Le code HTML n'est pas autorisé.